Retractable Technologies, Inc. (RVP)

USD 0.59

(-8.8%)

Market Cap (In USD)

17.69 Million

Revenue (In USD)

43.59 Million

Net Income (In USD)

-7.01 Million

Avg. Volume

95.07 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.56-1.34
PE
-
EPS
-
Beta Value
2.061
ISIN
US76129W1053
CUSIP
76129W105
CIK
946563
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Thomas J. Shaw
Employee Count
-
Website
https://www.retractable.com
Ipo Date
2001-05-04
Details
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

More Stocks